FDA approves ixazomib

20 Nov 2015 11:58 AM | Lori Aubrey (Administrator)
FDA approved ixazomib in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.  

FDA Approvals

Comments

Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software